BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  Helsinn Announces That Pivotal Phase 3 Trial Data For Anamorelin In ROMANA 1 And 2 Studies In Non-Small Cell Lung Cancer Patients With Anorexia-Cachexia Will Be Presented At The 38th European Society For Medical Oncology (ESMO) Congress In 2014

  September 25, 2014

   · 

  3 min read
• Biotech Bay

  SI-BONE, Inc. Announces American Medical Association’s Publication Of New Category I CPT Code For MIS SI Joint Fusion

  September 25, 2014

   · 

  3 min read
• Pharm Country

  Janssen Pharmaceutical Inc. Release: Study Observed Association Between JANSSEN® CONNECT® Injection Centers And Increased Adherence To Healthcare Provider-Ordered Janssen Long-Acting Treatment For People With Schizophrenia

  September 25, 2014

   · 

  13 min read
• Santen Pharmaceutical Release: Increase Of Capital For A Consolidated Subsidiary In Europe

  September 25, 2014

   · 

  2 min read
• Biotech Beach

  Amgen To Host Summary Webcast Of Kyprolis® (Carfilzomib) For Injection Data Presented At The European Society For Medical Oncology (ESMO) 2014 Congress

  September 25, 2014

   · 

  2 min read
• ProSensa Holding N.V. To Present At Upcoming Conferences

  September 25, 2014

   · 

  1 min read
• Biotech Bay

  Ekso Bionics To Present At AHIMA’s Annual Convention & Exhibit: Leading The Way To Health Intelligence

  September 25, 2014

   · 

  4 min read
• BioMidwest

  Unique IMRIS Hybrid OR Enables Highly Complex Deformity Correction At Dartmouth Hitchcock Medical Center

  September 25, 2014

   · 

  2 min read
• Policy

  Shire Shells Out $56.5 Million To Settle False Marketing Claims

  September 25, 2014

   · 

  5 min read
• Drug Development

  TRACON Pharmaceuticals, Inc. Announces Results From Clinical Trials Of TRC105 In Patients With Ovarian Cancer To Be Presented At The 2014 Annual Meeting Of The European Society For Medical Oncology

  September 25, 2014

   · 

  2 min read